CLPTM1L anticorps (AA 32-172) (Biotin)
-
- Antigène Voir toutes CLPTM1L Anticorps
- CLPTM1L (CLPTM1-Like (CLPTM1L))
-
Épitope
- AA 32-172
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLPTM1L est conjugé à/à la Biotin
-
Application
- ELISA
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Cleft lip and palate transmembrane protein 1-like protein (32-172AA)
- Isotype
- IgG
- Top Product
- Discover our top product CLPTM1L Anticorps primaire
-
anti-CLPTM1-Like (CLPTM1L) (AA 32-172) antibody
CLPTM1L Reactivité: Humain ELISA, WB, IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-CLPTM1-Like (CLPTM1L) (Middle Region) antibodyCLPTM1L Reactivité: Humain, Souris, Rat, Lapin, Boeuf (Vache), Chien, Cobaye, Cheval, Poisson zèbre (Danio rerio) WB, IHC Hôte: Lapin Polyclonal unconjugated
anti-CLPTM1-Like (CLPTM1L) (AA 509-538), (C-Term) antibodyCLPTM1L Reactivité: Humain WB Hôte: Lapin Polyclonal RB24286 unconjugated
anti-CLPTM1-Like (CLPTM1L) (AA 467-516) antibodyCLPTM1L Reactivité: Humain, Souris, Rat, Lapin, Boeuf (Vache), Chien, Cobaye, Cheval, Roussette (Chauve-souris), Hamster, Porc, Xenopus laevis WB, IHC, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-CLPTM1-Like (CLPTM1L) (Middle Region) antibodyCLPTM1L Reactivité: Humain, Souris, Rat WB Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- CLPTM1L (CLPTM1-Like (CLPTM1L))
- Autre désignation
- CLPTM1L (CLPTM1L Produits)
- Synonymes
- anticorps CRR9, anticorps C130052I12Rik, anticorps Crr9, anticorps RGD1307896, anticorps C130052I12RIK, anticorps CLPTM1 like, anticorps CLPTM1-like, anticorps cleft lip and palate transmembrane protein 1-like protein, anticorps CLPTM1L, anticorps clptm1l, anticorps LOC100338302, anticorps Clptm1l
- Sujet
-
Background: Enhances cisplatin-mediated apoptosis, when overexpressed.
Aliases: C130052I12Rik antibody, Cisplatin resistance related protein 9 antibody, Cisplatin resistance related protein CRR9p antibody, Cisplatin resistance-related protein 9 antibody, Cleft lip and palate transmembrane protein 1 like protein antibody, Cleft lip and palate transmembrane protein 1-like protein antibody, CLP1L_HUMAN antibody, CLPTM1 like antibody, CLPTM1 like protein antibody, CLPTM1-like protein antibody, CLPTM1L antibody, CRR9 antibody, CRR9p antibody, DKFZp666M1010 antibody, DKFZp761M2324 antibody, FLJ14400 antibody, FLJ32533 antibody, MGC36304 antibody, OTTHUMP00000220655 antibody, RGD1307896 antibody
- UniProt
- Q96KA5
-
